Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMitchells & Butlers Regulatory News (MAB)

Share Price Information for Mitchells & Butlers (MAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 295.00
Bid: 295.50
Ask: 297.50
Change: 0.00 (0.00%)
Spread: 2.00 (0.677%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 295.00
MAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

REPLACEMENT FOR 15/9/11Form 8.5 MITCHELLS&BUTLERS

21 Sep 2011 10:52

RNS Number : 6496O
Nomura International PLC (EPT)
21 September 2011
 



This announcement replaces the previous RNS announcement 30450 released at 11.50 am on the 15th September 2011. Amendments made to interests in 2 (a). All other information remains unchanged.

 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nomura International Plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Mitchells & Butlers Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Mitchells & Butlers Plc

(d) Date position held/dealing undertaken:

14 September 2011

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

NO

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

8 13/24p ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

165,283

0.040%

122,201

0.030%

(2) Derivatives (other than options):

(3) Options and agreements to purchase/sell:

 

TOTAL:

165,283

0.040%

122,201

0.030%

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary Shares

Purchase

179

2.494

Ordinary Shares

Purchase

936

2.495

Ordinary Shares

Purchase

1600

2.500

Ordinary Shares

Purchase

279

2.511

Ordinary Shares

Purchase

728

2.518

Ordinary Shares

Purchase

977

2.522

Ordinary Shares

Purchase

123

2.524

Ordinary Shares

Purchase

385

2.525

Ordinary Shares

Purchase

217

2.526

Ordinary Shares

Purchase

89

2.528

Ordinary Shares

Purchase

3583

2.529

Ordinary Shares

Purchase

343

2.534

Ordinary Shares

Purchase

377

2.542

Ordinary Shares

Purchase

186

2.546

Ordinary Shares

Purchase

933

2.549

Ordinary Shares

Purchase

1727

2.550

Ordinary Shares

Purchase

1176

2.552

Ordinary Shares

Purchase

915

2.557

Ordinary Shares

Purchase

4340

2.558

Ordinary Shares

Purchase

2111

2.559

Ordinary Shares

Purchase

445

2.563

Ordinary Shares

Purchase

1693

2.564

Ordinary Shares

Purchase

5923

2.565

Ordinary Shares

Purchase

9495

2.566

Ordinary Shares

Purchase

1954

2.567

Ordinary Shares

Purchase

14294

2.569

Ordinary Shares

Purchase

457

2.570

Ordinary Shares

Purchase

1242

2.571

Ordinary Shares

Purchase

3898

2.572

Ordinary Shares

Purchase

534

2.573

Ordinary Shares

Purchase

2273

2.574

Ordinary Shares

Purchase

6443

2.575

Ordinary Shares

Purchase

7112

2.576

Ordinary Shares

Purchase

25856

2.577

Ordinary Shares

Purchase

8352

2.578

Ordinary Shares

Purchase

10788

2.579

Ordinary Shares

Purchase

21341

2.580

Ordinary Shares

Purchase

9374

2.581

Ordinary Shares

Purchase

5025

2.582

Ordinary Shares

Purchase

38137

2.583

Ordinary Shares

Purchase

397

2.584

Ordinary Shares

Purchase

29302

2.585

Ordinary Shares

Purchase

4794

2.586

Ordinary Shares

Purchase

4674

2.587

Ordinary Shares

Purchase

10706

2.588

Ordinary Shares

Purchase

2532

2.589

Ordinary Shares

Purchase

748

2.590

Ordinary Shares

Purchase

6941

2.591

Ordinary Shares

Purchase

5136

2.592

Ordinary Shares

Purchase

3938

2.593

Ordinary Shares

Purchase

685

2.594

Ordinary Shares

Purchase

270

2.595

Ordinary Shares

Purchase

11304

2.599

Ordinary Shares

Purchase

46454

2.600

Ordinary Shares

Purchase

25212

2.601

Ordinary Shares

Purchase

12045

2.602

Ordinary Shares

Purchase

3561

2.603

Ordinary Shares

Purchase

3737

2.604

Ordinary Shares

Purchase

3200

2.605

Ordinary Shares

Purchase

1412

2.606

Ordinary Shares

Purchase

7238

2.607

Ordinary Shares

Purchase

3102

2.608

Ordinary Shares

Purchase

363

2.609

Ordinary Shares

Purchase

528

2.611

Ordinary Shares

Sale

1713

2.489

Ordinary Shares

Sale

340

2.503

Ordinary Shares

Sale

1278

2.506

Ordinary Shares

Sale

2665

2.526

Ordinary Shares

Sale

543

2.535

Ordinary Shares

Sale

3099

2.537

Ordinary Shares

Sale

1268

2.542

Ordinary Shares

Sale

495

2.543

Ordinary Shares

Sale

358

2.545

Ordinary Shares

Sale

2462

2.549

Ordinary Shares

Sale

427

2.553

Ordinary Shares

Sale

1447

2.557

Ordinary Shares

Sale

1278

2.564

Ordinary Shares

Sale

8271

2.565

Ordinary Shares

Sale

1804

2.566

Ordinary Shares

Sale

5562

2.567

Ordinary Shares

Sale

6817

2.569

Ordinary Shares

Sale

3337

2.570

Ordinary Shares

Sale

8738

2.571

Ordinary Shares

Sale

2483

2.572

Ordinary Shares

Sale

2914

2.573

Ordinary Shares

Sale

2626

2.574

Ordinary Shares

Sale

42342

2.575

Ordinary Shares

Sale

14664

2.576

Ordinary Shares

Sale

8407

2.577

Ordinary Shares

Sale

4721

2.578

Ordinary Shares

Sale

5108

2.579

Ordinary Shares

Sale

5709

2.580

Ordinary Shares

Sale

3423

2.581

Ordinary Shares

Sale

20687

2.582

Ordinary Shares

Sale

2288

2.582

Ordinary Shares

Sale

2598

2.583

Ordinary Shares

Sale

16123

2.584

Ordinary Shares

Sale

15332

2.585

Ordinary Shares

Sale

2123

2.586

Ordinary Shares

Sale

2013

2.587

Ordinary Shares

Sale

11406

2.588

Ordinary Shares

Sale

10534

2.589

Ordinary Shares

Sale

10535

2.590

Ordinary Shares

Sale

11617

2.591

Ordinary Shares

Sale

1667

2.592

Ordinary Shares

Sale

85122

2.592

Ordinary Shares

Sale

2371

2.593

Ordinary Shares

Sale

3002

2.594

Ordinary Shares

Sale

495

2.597

Ordinary Shares

Sale

2200

2.599

Ordinary Shares

Sale

36597

2.600

Ordinary Shares

Sale

8978

2.601

Ordinary Shares

Sale

8854

2.602

Ordinary Shares

Sale

6373

2.603

Ordinary Shares

Sale

8942

2.604

Ordinary Shares

Sale

5183

2.605

Ordinary Shares

Sale

352

2.606

Ordinary Shares

Sale

11047

2.607

Ordinary Shares

Sale

2152

2.608

Ordinary Shares

Sale

4362

2.609

Ordinary Shares

Sale

1614

2.610

Ordinary Shares

Sale

86

2.613

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

21 September 2011

Contact name:

Kyere Tabiri

Telephone number:

020 7102 1267

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOEANNFALNFEEF
Date   Source Headline
31st May 202411:30 amRNSTotal Voting Rights
28th May 20242:30 pmRNSDirector/PDMR Shareholding
22nd May 20247:00 amRNSHalf Year Results
17th May 202410:00 amRNSNotice of Half Year Results
30th Apr 202411:00 amRNSTotal Voting Rights
29th Apr 20243:08 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:45 pmRNSDirector/PDMR Shareholding
2nd Apr 20241:30 pmRNSBlock listing Interim Review
28th Mar 20241:00 pmRNSTotal Voting Rights
4th Mar 202412:30 pmRNSDirector/PDMR Shareholding
29th Feb 20242:00 pmRNSTotal Voting Rights
5th Feb 20243:30 pmRNSDirector/PDMR Shareholding
31st Jan 20242:21 pmRNSDirector/PDMR Shareholding
31st Jan 202410:00 amRNSTotal Voting Rights
23rd Jan 202412:16 pmRNSResult of Annual General Meeting
17th Jan 20247:00 amRNSFirst Quarter Trading Update
15th Jan 20241:00 pmRNSNotice of First Quarter Trading Update
8th Jan 20242:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20242:00 pmRNSTotal Voting Rights
22nd Dec 20239:36 amRNSDirectorate Declaration
20th Dec 202312:00 pmRNSAnnual Report 2023
14th Dec 20232:30 pmRNSDirector/PDMR Shareholding
11th Dec 20234:35 pmRNSDirector/PDMR Shareholding
8th Dec 202311:30 amRNSDirector/PDMR Shareholding
7th Dec 202310:30 amRNSDirector/PDMR Shareholding
30th Nov 202311:30 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSFULL YEAR RESULTS
24th Nov 202312:00 pmRNSNotice of Final Results
14th Nov 202310:45 amRNSDirector/PDMR Shareholding
13th Nov 20232:30 pmRNSDirector/PDMR Shareholding
31st Oct 20231:00 pmRNSTotal Voting Rights
31st Oct 202310:00 amRNSDirectorate Declaration
16th Oct 20232:00 pmRNSDirector/PDMR Shareholding
9th Oct 20233:46 pmRNSListing Application
2nd Oct 20232:30 pmRNSBlock listing Interim Review
28th Sep 20237:00 amRNSFourth Quarter Trading Update
25th Sep 202312:00 pmRNSNotice of Fourth Quarter Trading Statement
18th Sep 20233:00 pmRNSDirector/PDMR Shareholding
15th Sep 20232:20 pmRNSDirector/PDMR Shareholding
15th Sep 20232:15 pmRNSDirector/PDMR Shareholding
31st Aug 20232:32 pmRNSTotal Voting Rights
21st Aug 20232:30 pmRNSDirector/PDMR Shareholding
31st Jul 20231:14 pmRNSTotal Voting Rights
27th Jul 20237:00 amRNSThird Quarter Trading Update
24th Jul 20232:50 pmRNSDirector/PDMR Shareholding
21st Jul 202312:06 pmRNSNotice of Third Quarter Trading Update
30th Jun 202310:30 amRNSTotal Voting Rights
26th Jun 202311:15 amRNSDirector/PDMR Shareholding
31st May 20233:15 pmRNSTotal Voting Rights
30th May 20233:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.